Literature DB >> 19439990

Factors associated with vascular stiffness: cross-sectional analysis from the Chronic Renal Insufficiency Standards Implementation Study.

Helen Eddington1, Smeeta Sinha, Elizabeth Li, Janet Hegarty, Jeanette Ting, Beverley Lane, Constantina Chrysochou, Robert Foley, Donal O'Donoghue, Philip A Kalra, Rachel Middleton.   

Abstract

BACKGROUND: Vascular stiffness is associated with increased cardiovascular risk. This study aimed to identify factors associated with vascular stiffness in a cohort of chronic kidney disease (CKD) patients.
METHODS: The Chronic Renal Insufficiency Standards Implementation Study is a prospective epidemiological study of CKD patients not on dialysis, who are managed in a clinic setting. Phenotypic parameters were collected annually, and vascular stiffness was assessed using augmentation index (AI). Cross-sectional analysis was performed across quintiles of AI to evaluate factors associated with vascular stiffness.
RESULTS: Mean patient age was 66.1 +/- 14.1 years and estimated glomerular filtration rate (eGFR) was 31.2 +/- 5.7 ml/min. Corrected calcium was 2.26 +/- 0.2 SD mmol/l, phosphate 1.2 +/- 0.4 SD mmol/l and intact parathyroid hormone 94 +/- 96 SD pg/ml; 18.3% of patients had cardiovascular disease. Increased age and systolic blood pressure were associated with increased AI (all p < 0.001). No statistical association was present between AI and eGFR, intact parathyroid hormone, phosphate or protein excretion.
CONCLUSION: This study identified blood pressure as a potentially modifiable risk factor associated with AI, whereas eGFR was not associated with increased AI in a population of CKD stage 3-5 patients. Further knowledge of factors which influence progression of vascular stiffness will be important in risk quantification and management. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19439990     DOI: 10.1159/000218108

Source DB:  PubMed          Journal:  Nephron Clin Pract        ISSN: 1660-2110


  5 in total

1.  The natural history of, and risk factors for, progressive chronic kidney disease (CKD): the Renal Impairment in Secondary care (RIISC) study; rationale and protocol.

Authors:  Stephanie Stringer; Praveen Sharma; Mary Dutton; Mark Jesky; Khai Ng; Okdeep Kaur; Iain Chapple; Thomas Dietrich; Charles Ferro; Paul Cockwell
Journal:  BMC Nephrol       Date:  2013-04-25       Impact factor: 2.388

2.  The relationship between mean arterial pressure and decreased glomerular filtration rate in rural areas of Northeast China.

Authors:  Hongmei Yang; Xiaofan Guo; Xingang Zhang; Zhao Li; Shasha Yu; Liqiang Zheng; Wenna Li; Ying Zhou; Yingxian Sun
Journal:  BMC Nephrol       Date:  2015-08-13       Impact factor: 2.388

3.  Chronic kidney disease stage is a modulator on the association between high-sensitivity C-reactive protein and coronary vasospastic angina.

Authors:  Heng-Jung Hsu; Chiung-Hui Yen; Kuang-Hung Hsu; I-Wen Wu; Chin-Chan Lee; Chiao-Yin Sun; Chia-Chi Chou; Chun-Yu Chen; Shih-Ying Yang; Chi-Jen Tsai; Mai-Szu Wu; Ming-Jui Hung
Journal:  ScientificWorldJournal       Date:  2014-03-05

4.  Relationship of arterial compliance and blood pressure with microalbuminuria and mildly decreased glomerular filtration rate: a Chinese community-based analysis.

Authors:  Shihui Fu; Yuqing Sun; Leiming Luo; Ping Ye
Journal:  PLoS One       Date:  2014-06-25       Impact factor: 3.240

5.  Impact of chronic kidney disease on use of evidence-based therapy in stable coronary artery disease: a prospective analysis of 22,272 patients.

Authors:  Paul R Kalra; Xavier García-Moll; José Zamorano; Philip A Kalra; Kim M Fox; Ian Ford; Roberto Ferrari; Jean-Claude Tardif; Michal Tendera; Nicola Greenlaw; Ph Gabriel Steg
Journal:  PLoS One       Date:  2014-07-22       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.